Cystic Fibrosis Transmembrane Conductance Regulator Correctors
DBCAT005703Pharmacologic class
Agents which act as correctors of cystic fibrosis transmembrane conductance regulator (CFTR). A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of November 29, 2022
Which targets do Cystic Fibrosis Transmembrane Conductance Regulator Correctors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account